Results 151 to 160 of about 640,823 (337)
Abstract Aims Mineralocorticoid receptor antagonists (MRAs) are crucial in managing cardiovascular diseases, with different MRAs demonstrating varying efficacy across diverse disease contexts. This research aims to compare the cardiovascular protective effects of different MRAs across various disease conditions.
Jiao Wang+4 more
wiley +1 more source
On the use of clustering and the MeSH controlled vocabulary to improve MEDLINE abstract search [PDF]
Databases of genomic documents contain substantial amounts of structured information in addition to the texts of titles and abstracts. Unstructured information retrieval techniques fail to take advantage of the structured information available.
Blott, Stephen+3 more
core
Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta‐analysis. Clonal haematopoiesis and heart failure: a meta‐analysis. CH, clonal haematopoiesis; CI, confidence interval; HF, heart failure. [Correction added on 15 March 2025, after first online publication: The graphical image was corrected in ...
Paschalis Karakasis+8 more
wiley +1 more source
Hazards of translation of non-English medical publications in Medline [PDF]
Orhan Sezer, Angelika Böhme
openalex +1 more source
Abstract Aims Sudden cardiac death (SCD) is a prevalent cause of mortality among patients with cardio‐kidney‐metabolic (CKM) diseases. Mineralocorticoid receptor antagonists (MRAs) reduce the risk of SCD in patients with left ventricular dysfunction, but it is unclear if similar effects are expected across different CKM risk populations irrespective of
Pedro Marques+2 more
wiley +1 more source
This systematic review included seven studies that reported the outcomes of minimization or withdrawal of oral pharmacotherapy in chronic heart failure (HF) patients with improved myocardial function. There is a dearth of existing evidence, which supports only loop diuretic withdrawal and possibly carvedilol monotherapy.
Yuxiang Luo+8 more
wiley +1 more source
Abstract We conducted a systematic review and meta‐analysis of randomized controlled trials (RCTs) evaluating the efficacy of levetiracetam (LEV) compared to placebo in improving cognitive performance in people with cognitive decline. The protocol was pre‐registered with PROSPERO (CRD420250656389) and reporting followed PRISMA guidelines.
Claudia Faini+2 more
wiley +1 more source
Psychiatric research in South Africa : a systematic review of Medline publications [PDF]
Johan Fourie+3 more
openalex +1 more source